Director, Regulatory Affairs, Switzerland
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
We are seeking a highly motivated and experienced professional to join our team as a Director, Regulatory Affairs, Switzerland. Key aspects of this role will include leading and providing strategic input on all regulatory activities for assigned projects and products in Switzerland, in accordance with applicable Swiss legislation, Swissmedic requirements, ICH requirements, and company policies and procedures, cross-functionally engaging in a team of regulatory professionals at global and European level supporting both
